Patricia A. Bradford
Patricia A. Bradford has made 2 open-market purchases worth $19k since Sep 16, 2026, in 1 company. The latest: $7k of PHIO, filed Sep 25, 2026, scored 25 out of 100.
Director, Phio Pharmaceuticals Corp.
Follow Patricia A. Bradford, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Sep 25 Form 4 (opens sec.gov) |
PHIOPhio Pharmaceuticals Corp. · DirectorDirector · Near 52-week low · Penny stock: hard to trade | +11% stake | 25 | $7k 6,500 at $1.01 |
— | — |
| Sep 16 Form 4 (opens sec.gov) |
PHIOPhio Pharmaceuticals Corp. · DirectorDirector · Near 52-week low · Penny stock: hard to trade | +26% stake | 30 | $12k 12,000 at $1.03 |
— | — |
Questions
What stock has Patricia A. Bradford bought?
PHIO (Phio Pharmaceuticals Corp.), all on the open market and reported on SEC Form 4.
When did Patricia A. Bradford last buy?
Sep 25, 2026: 6,500 shares of PHIO at $1.01, $7k in all (Form 4 (opens sec.gov)).
Has Patricia A. Bradford filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Patricia A. Bradford a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Sep 25, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer